Cyclo Therapeutics Inc (CYTH)

• $0.65

  $0.69

  $0.68
  

  4.41%

  Downside

  Day's Volatility :5.8%

  Upside

  1.45%

  
• $0.65

  $2.12

  $0.68
  

  4.41%

  Downside

  52 Weeks Volatility :69.27%

  Upside

  67.85%

  

Returns

What analysts predicted

Upside of 39.71%

• EPIQ Capital Group, LLC

  2.85%

• Founders Fund V Management, LLC

  1.68%

• Vanguard Group Inc

  1.56%

• Geode Capital Management, LLC

  0.56%

• Founders Fund VI Management, LLC

  0.38%

• BlackRock Inc

  0.21%

cyclodextrin technologies development, inc. (ctd), the "company"​, was organized as a florida corporation on august 9, 1990 with operations beginning july, 1992. in may of 1994 the company became a fully reporting public company listed on the otc bb under the symbol ctdi. in 2000, the company altered its corporate structure to a holding company with subsidiary companies. the otc bb symbol was changed to ctdh. ctd holdings, inc. (the "company"​) was originally formed to market and sell cyclodextrins and related products to the food, pharmaceutical, and other industries; it also provided consulting services related to cyclodextrin technology. ctdh, as a holding company, will acquire, create, and invest in companies that will develop, market, and/or sell products containing cyclodextrins. the company currently operates four wholly owned subsidiaries: ctd, inc.; nanosonic products, inc.; sphingo biotech, inc.; and ferrazo environmental technologies, inc.